Moberg Pharma AB (MBPH)

Stockholm
Currency in SEK
7.82
+0.07(+0.90%)
Closed
MBPH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
7.677.90
52 wk Range
6.3440.90
Moberg Pharma AB is currently considered to be UndervaluedExplore our list of undervalued stocks for hidden opportunities
Key Statistics
Edit
Prev. Close
7.75
Open
7.75
Day's Range
7.67-7.9
52 wk Range
6.34-40.9
Volume
120.75K
Average Volume (3m)
257.91K
1-Year Change
-55.71%
Book Value / Share
14.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MBPH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
No news in this category
Looks like there are no results in this news category

Moberg Pharma Company Profile

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.

Employees
9
Market
Sweden

Compare MBPH to Peers and Sector

Metrics to compare
MBPH
Peers
Sector
Relationship
P/E Ratio
−1.4x−5.2x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.5x5.0x2.6x
Price / LTM Sales
37.2x4.3x3.0x
Upside (Analyst Target)
41.9%30.7%53.8%
Fair Value Upside
Unlock10.2%9.6%Unlock

Earnings

Latest Release
Feb 11, 2025
EPS / Forecast
-- / -0.12
Revenue / Forecast
-- / 600.00K
EPS Revisions
Last 90 days

FAQ

What Is the Moberg Pharma (MBPH) Stock Price Today?

The Moberg Pharma stock price today is 7.82

What Stock Exchange Does Moberg Pharma Trade On?

Moberg Pharma is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Moberg Pharma?

The stock symbol for Moberg Pharma is "MBPH."

What Is the Moberg Pharma Market Cap?

As of today, Moberg Pharma market cap is 365.14M.

What is Moberg Pharma Earnings Per Share?

The Moberg Pharma EPS is -6.74.

What Is the Next Moberg Pharma Earnings Date?

Moberg Pharma will release its next earnings report on 12 May 2025.

From a Technical Analysis Perspective, Is MBPH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.